---
schema_version: "secwatch.filing_event.v1"
accession: "0000805928-24-000037"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T00:57:20.071246+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Axogen Chief R&D Officer Scopelianos resigns; transition consulting through Dec 2024

## Summary
- Angelo Scopelianos resigns as Chief R&D Officer effective no later than March 31, 2024.
- He will consult up to 10 hrs/wk from Apr 1 to Dec 31, 2024 for $9,079.16/month plus a $75,000 one-time payment if through Oct 1.
- Scopelianos receives his 2023 bonus of $228,385.26 on March 15, 2024.
- Unvested stock options continue vesting through consulting period; RSUs and unvested PSUs cease at separation.
- Product development duties assumed by VP Stacy Arnold, who reports directly to CEO.

## SEC filing metadata
- accession: 0000805928-24-000037
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000080592824000037/0000805928-24-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000080592824000037/axgn-20240307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000805928-24-000037
- JSON: https://secwatch.observer/filing/0000805928-24-000037.json
- Plain text: https://secwatch.observer/filing/0000805928-24-000037.txt

## Key facts
- Executive change
  Angelo Scopelianos resigned as Chief Research and Development Officer at Axogen, Inc..
  - Action: resigned
  - Role: Chief Research and Development Officer
  source text: Angelo Scopelianos notified Axogen, Inc. (the “Company”) of his intention to resign as the Company’s Chief Research and Development Officer no later than March 31, 2024 (the “Separation Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000080592824000037/0000805928-24-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.